An Atypical Presentation of Neurosyphilis Mimicking Myasthenia Gravis
Hammad Siddiqui1, Haris Khan2, Laith Hamed3, Arsalan Ali4
1Texas College of Osteopathic Medicine, 2UNTHSC College of Biomedical and Translational Sciences, 3USF Morsani College of Medicine, 4University of Texas at Dallas
Objective:
To present an atypical case of neurosyphilis masking as suspected Myasthenia Gravis at initial time of presentation.
Background:
Neurosyphilis is a CNS infection caused by Treponema Pallidum and typically presents with a plethora of symptoms ranging from tabes dorsalis, cranial nerve palsies, stroke-like symptoms, and personality changes. Due to the multitude and variation of symptoms aligning with other disease states, neurosyphilis is known as the great Mimicker.
Design/Methods:
N/A
Results:

A 53-year-old male with past medical history of rectal polyps, prior stroke, motor vehicular accident, and type 2 diabetes, presented with severe constipation for two months with a two-week history of blurry vision, ataxia, bilateral ptosis, dysphagia, and dysarthria. Physical examination revealed ⅘ strength in the bilateral lower extremities, areflexia, and decreased sensation to pinprick and light touch. He was initially diagnosed with Myasthenia Gravis, for which he was started on Mestinon. Imaging studies yielded no acute intracranial abnormalities or large vessel occlusion/stenosis. A lumbar puncture was performed, which showed elevated protein and leukocytosis. He was then started on a 5-day course of IVIG for suspected Miller-Fisher syndrome.

CSF culture was negative for GQ1b antibody, and viral PCR for VZV and HSV 1 & 2 yielded negative results. ANA, MPO IgG, and proteinase–3 IgG were also negative.  His RPR titer result was positive at 1:64, as well as a positive CSF VDRL, which confirmed the diagnosis of neurosyphilis. He was started on IV penicillin, and showed marked improvement in his symptoms. 


Conclusions:

Patients presenting with subacute neurologic symptoms and indeterminate workups should have neurosyphilis as a differential diagnosis. CSF analysis and serologic testing facilitate early diagnosis and treatment planning, which are critical for timely clinical recovery.


10.1212/WNL.0000000000213127
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.